Friday 29 September 2023 - 03:29
In Business 43 Years - Since 1980
NOTE: our usual phone and fax lines are down, due to a dispute between our landlord and Verizon.
In the meantime, please use this mobile phone number: 978-715-9327 and this fax number:
The 25% Discount for Shopping Cart Purchases is now PERMANENT !!
For Online Shopping Cart Orders Only
In-Stock Sizes Only
See Check-out Page For Further Details
FREE SHIPPING TO THE U.S. AND 32 OTHER COUNTRIES! [Read more].
Search:
D-5699 Dabrafenib, Methanesulfonate Salt, >99%
Synonyms : [Dabrafenib Mesylate] [GSK2118436] [GSK2118436B]
Related Terms : [Tafinlar]
- Size
- US $
- €
- £
- ¥
- 10 mg
- 44
- 41
- 36
- 6,600
- In stock
- 25 mg
- 69
- 65
- 56
- 10,300
- In stock
- 50 mg
- 77
- 73
- 63
- 11,500
- In stock
- 100 mg
- 128
- 121
- 104
- 19,100
- In stock
- 200 mg
- 199
- 188
- 163
- 29,700
- In stock
- 500 mg
- 292
- 277
- 239
- 43,600
- In stock
- 1 g
- 443
- 420
- 363
- 66,200
- In stock
- 2 g
- 770
- 730
- 631
- 115,000
- In stock
- 5 g
- 1,740
- 1,651
- 1,426
- 259,800
- In stock
- 10 g
- 2,660
- 2,524
- 2,181
- 397,200
- In stock
Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.
To receive a Formal Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities
Free Shipping and Handling to the U.S. and 32 Other Countries
- M.W. 615.67
- C23H20F3N5O2S2CH4O3S
- [1195768-06-9]
- This research compound is the methanesulfonate salt form of dabrafenib. Please see the free base form of dabrafenib, Cat. No. D-5678, Dabrafenib, Free Base, for further technical information.
- This dabrafenib product is the methanesulfonate salt, whose CAS number is given above. The CAS number of the free base form is 1195765-45-7.
- Dabrafenib Methanesulfonate Salt is the active ingredient in the drug product sold under the trade name Tafinlar®. This drug has been approved in at least one country for use in patients with mutated metastatic melanoma. NOTE: THE DABRAFENIB SOLD BY LC LABORATORIES FOR RESEARCH IS NOT TAFINLAR®, AND IS NOT FOR HUMAN USE.
- Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use
- This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
- Not available in some countries; not available to some institutions; not available for some uses.
